Animal Models of Ebolavirus Infection

• Published in: Comparative medicine Vol. 67; no. 3; pp. 253 - 262
• Main Authors: St Claire, Marisa C, Ragland, Dan R, Bollinger, Laura, Jahrling, Peter B
• Format: Journal Article
• Language: English
• Published: United States American Association for Laboratory Animal Science 01.06.2017
• Subjects: Animals; Callithrix; Cricetinae; Disease Models, Animal; Disease Outbreaks; Guinea Pigs; Hemorrhagic Fever, Ebola; Macaca; Mice; Research Design; Special Topic Overviews
• ISSN: 1532-0820; 2769-819X; 2769-819X

Ebola virus is a highly pathogenic member of the family Filoviridae that causes a severe hemorrhagic disease in humans and NHP. The 2013-2016 West African outbreak has increased interest in the development and refinement of animal models of Ebola virus disease. These models are used to test countermeasures and vaccines, gain scientific insights into the mechanisms of disease progression and transmission, and study key correlates of immunology. Ebola virus is classified as a BSL4 pathogen and Category A agent, for which the United States government requires preparedness in case of bioterrorism. Rodents, such as Syrian golden hamsters (Mesocricetus auratus), mice (Mus musculus), and guinea pigs (Cavia porcellus), are the most common research species. However, NHP, especially macaques, are favored for Ebola virus disease research due to similarities with humans regarding the pathogenesis, clinical presentation, laboratory findings, and causes of fatality. To satisfy the regulatory requirements for approval of countermeasures against high-consequence pathogens, the FDA instituted the Animal Rule, which permits efficacy studies in animal models in place of human clinical data when such studies are not feasible or ethical. This review provides a comprehensive summary of various animal models and their use in Ebola virus disease research.